Malignant pleural mesothelioma: new treatments, new hopes?

Arnaud Scherpereel

Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Journal Issue: March
Disease area: Thoracic oncology

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Arnaud Scherpereel. Malignant pleural mesothelioma: new treatments, new hopes?. Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014



Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016


Malignant pleural mesothelioma: our multimodality approach
Source: Eur Respir J 2002; 20: Suppl. 38, 40s
Year: 2002

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016



Treatment of malignant pleural mesothelioma: dilemmas
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Malignant mesothelioma: new treatment advances, including targeted therapies
Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care
Year: 2021


Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Source: Eur Respir Rev 2015; 24: 115-131
Year: 2015



Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Phenotyping malignant pleural effusions: why?
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Malignant mesothelioma: recent experience
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Nonmalignant pleural effusions: are they as benign as we think?
Source: Eur Respir Monogr 2020; 87: 218-231
Year: 2020


Malignant pleural effusion: different treatments through countries
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Evaluation of response to chemotherapy for malignant pleural mesothelioma and suggestion of a new method
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Recent developments in the systemic treatment of malignant pleural mesothelioma: a light at the end of the tunnel!
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019


Keynote lecture: Introduction: Treatment options and tumour biology of malignant pleural mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019
Year: 2020



ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Guideline 2020
Year: 2020